Evidence map›Paper›PMID 33997476›Full record

ArticleClinical epidemiology and global health

The predictors of high titer of

Shinta Oktya Wardhani, Jonny Karunia Fajar, Nina Nurarifah, Djoko Heri Hermanto, Siti Fatonah, Susanthy Djajalaksana, Arie Zainul Fatoni, Putu Moda Arsana, Laksmi Wulandari, Gatot Soegiarto and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology and global health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Shinta Oktya WardhaniDivision of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Jonny Karunia FajarBrawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Nina NurarifahDivision of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Djoko Heri HermantoDivision of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Siti FatonahDepartment Clinical Pathology, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Susanthy DjajalaksanaDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Arie Zainul FatoniDepartment of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia.
Putu Moda ArsanaDivision of Endocrinology, Diabetes & Metabolism, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia.
Laksmi WulandariDepartment of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia.
Gatot SoegiartoDivision of Allergy & Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia.
Kuldeep DhamaDivision of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India.
Harapan HarapanMedical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, 23111, Indonesia.
University of Brawijaya · IDAirlangga University · IDIndian Veterinary Research Institute · INUniversitas Syiah Kuala · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent evidence suggested that the higher titers of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody from convalescent plasma donors contributed to the clinical improvement in coronavirus disease 2019 (COVID-19) patients. However, the titers of

objectivesTo assess the factors associated with high titers of

methodsA cross-sectional study was conducted in Saiful Anwar General Hospital, Malang, Indonesia. Information of interest including demographic characteristics, clinical symptoms, comorbidities, laboratory findings, and the titers of

resultsA total of 50 COVID-19 CCP donors with the titers of

conclusionsCPP donors who had experience of symptomatic COVID-19 with high eosinophils level, high immature granulocytes and low albumin level have higher titers of

Indexed as

Convalescent plasmaCOVID-19DonorsPredictorTiters of antibody

Identifiers

PMID33997476
PMCPMC8108475
OpenAlexW3163637728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.